company background image
300147 logo

Xiangxue PharmaceuticalLtd XSEC:300147 Stock Report

Last Price

CN¥3.20

Market Cap

CN¥2.1b

7D

-3.9%

1Y

-39.3%

Updated

29 Jun, 2024

Data

Company Financials

Xiangxue Pharmaceutical Co.,Ltd.

XSEC:300147 Stock Report

Market Cap: CN¥2.1b

300147 Stock Overview

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China.

300147 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Xiangxue Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Xiangxue PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥3.20
52 Week HighCN¥6.45
52 Week LowCN¥3.00
Beta0.66
11 Month Change-9.09%
3 Month Change-27.44%
1 Year Change-39.28%
33 Year Change-60.25%
5 Year Change-51.73%
Change since IPO-77.39%

Recent News & Updates

Recent updates

Shareholder Returns

300147CN PharmaceuticalsCN Market
7D-3.9%-3.7%-2.2%
1Y-39.3%-17.3%-17.9%

Return vs Industry: 300147 underperformed the CN Pharmaceuticals industry which returned -17.3% over the past year.

Return vs Market: 300147 underperformed the CN Market which returned -17.9% over the past year.

Price Volatility

Is 300147's price volatile compared to industry and market?
300147 volatility
300147 Average Weekly Movement9.2%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 300147's share price has been volatile over the past 3 months.

Volatility Over Time: 300147's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
19972,644Yonghui Wangwww.xphcn.com

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd.

Xiangxue Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Xiangxue PharmaceuticalLtd's earnings and revenue compare to its market cap?
300147 fundamental statistics
Market capCN¥2.12b
Earnings (TTM)-CN¥429.16m
Revenue (TTM)CN¥2.28b

0.9x

P/S Ratio

-4.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300147 income statement (TTM)
RevenueCN¥2.28b
Cost of RevenueCN¥1.57b
Gross ProfitCN¥713.37m
Other ExpensesCN¥1.14b
Earnings-CN¥429.16m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)-0.65
Gross Margin31.30%
Net Profit Margin-18.83%
Debt/Equity Ratio104.3%

How did 300147 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.